The Relationship between Increases in Morning Spot Urinary Glucose Excretion and Decreases in HbA1C in Patients with Type 2 Diabetes After Taking an SGLT2 Inhibitor: A Retrospective, Longitudinal Study
Sign Up to like & getrecommendations! Published in 2017 at "Diabetes Therapy"
DOI: 10.1007/s13300-017-0248-5
Abstract: AbstractIntroduction Sodium glucose co-transporter 2 (SGLT2) inhibitors increase urinary glucose excretion (UGE) by reducing the renal threshold for glucose excretion, which results in decreased serum glucose concentrations in patients with type 2 diabetes mellitus (T2D).… read more here.
Keywords: sglt2 inhibitor; urinary glucose; morning spot; morning ... See more keywords
Morning Spot Urine Glucose-to-Creatinine Ratios Predict Overnight Urinary Glucose Excretion in Patients With Type 2 Diabetes
Sign Up to like & getrecommendations! Published in 2017 at "Annals of Laboratory Medicine"
DOI: 10.3343/alm.2017.37.1.9
Abstract: Background With the advent of sodium glucose co-transporter 2 inhibitors to control glucose and treat diabetes, laboratory data aided by either timed or spot glucose levels in the urine could be used as an alternative… read more here.
Keywords: overnight urinary; spot; urine; morning spot ... See more keywords